CliniGA CRO

CliniGA CRO Blog

PMCF plans: turn evidence gaps into measurable questions

A useful PMCF plan starts with a residual clinical question, then selects a method capable of answering it.

Cover image for: PMCF plans: turn evidence gaps into measurable questions
Photo: Diane A. Reid (Photographer) · License: Public domain · Cropped and resized.
Published
Updated
Sources checked

A useful PMCF plan starts with a residual clinical question, then selects a method capable of answering it.

PMCF plans — Define the regulatory scope

MDR Annex XIV Part B sets the PMCF framework. MDCG 2020-7 offers a planning template; completing its headings does not prove that a method is adequate.

PMCF plans — Build the working record

Create a gap-to-activity table linking residual risk, long-term performance or population uncertainty to method, endpoint, sample rationale and review date. Explain why a registry, survey or specific study can provide relevant evidence.

PMCF plans — Check before release

  • Define the population and device variants.
  • State measurable outcomes and acceptable completeness.
  • Assign an escalation trigger for weak data.

PMCF plans — Record the decision and handover

Approve the plan with clinical evaluation and risk management owners. Record what finding would change the benefit-risk conclusion and how the resulting data will enter the evaluation report.

Frequently asked questions

Is every customer survey adequate PMCF?
No. Assess whether its design and data quality address the stated clinical question.
Can PMCF be justified as unnecessary?
Any justification must be device-specific and meet the applicable requirements; avoid a blanket waiver.

Sources

  1. Primary requirement: MDR Annex XIV Part B
  2. Operational guidance: MDCG 2020-7: PMCF plan